BCPC logo

BALCHEM CORP

BCPCNASDAQ
πŸ† #1249 by market capEarnings Oct 19US Equity
$167.15β–Ό $1.52 (βˆ’0.91%)
Market closed Β· at close
πŸ””
Track BCPC
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.9%
7dβ–Ό 0.9%
14dβ–Ό 0.1%
30dβ–Ό 5.1%
ytdβ–² 8.9%
1yβ–² 11.3%
🏦Market Cap
$5.37B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+8.8%
Slowing
πŸ“ŠGross Margin
36.3%
Healthy
πŸ’΅FCF Margin
15.8%
Healthy
βš–οΈP/S Ratio
5.0x
Fair
Otter Score
72
Fair

Trading Snapshot

Day Range
$166.44 – $169.53
52-Week Range
$139.17 – $183.90
Volume
$2.44B
Avg Volume
$2.47B
Shares Outstanding
32.1M
Next Earnings
Nov 17, 2026

Fundamentals Snapshot

Annual Revenue
$1.04B
Last Q Revenue
$284M
P/E Ratio
32.9
P/S Ratio
5.0x
EPS (TTM)
$5.10
Dividend Yield
0.57%
Dilution (1yr)
βˆ’0.7%

Why Investors Own BCPC

  • βœ“High-growth profile β€” revenue up +42.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 76% gross margin and 13% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

BCPC logo

BALCHEM CORP

BCPC
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.0Bβ–² +8.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
35.7%β–² +1.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$218Mβ–² +19.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$173Mβ–² +18.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
32.3Mβ–Ό βˆ’0.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$117Mβ–² +$41M YoY
StockOtter Β· stockotter.space

About BALCHEM CORP

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Ratings

β“˜
Consensus
Buy
9 analysts
Strong Buy2
Buy5
Hold2
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates

GlobeNewsWireΒ·21d ago

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells

Seeking AlphaΒ·Aug 1

Balchem: It's A Buy From Me After Posting Strong Q2 Results

Balchem Corporation posted Q2 results, with EPS of $1.49 beating estimates by $0.07, while surpassing the consensus by $15M and was up 11% YoY. All areas of the business posted impressive results, as the minimum revenue

Seeking AlphaΒ·Jul 31

Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript

Balchem Corporation (BCPC) Q2 2026 Earnings Call Transcript

Seeking AlphaΒ·Jul 31

Conestoga SMid Cap Composite Q2 2026 Portfolio Review

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperforme

GlobeNewsWireΒ·Jul 31

Balchem Corporation Reports Second Quarter 2026 Financial Results

MONTVALE, N.J., July 31, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today reported financial results for its 2026 fiscal second quarter ended June 30, 2026.

GlobeNewsWireΒ·Jul 17

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

MONTVALE, N.J., July 17, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 31, 2026, at 11:00 AM Eastern Time (ET) to review second quarter re